The DOI matches its Crossref record; 95 of the 99 references it cites were found in a registry or an index.
Targeted delivery of nanoparticles for the treatment of lung diseases
Abstract
Targeted delivery of drug molecules to organs or special sites is one of the most challenging research areas in pharmaceutical sciences. By developing colloidal delivery systems such as liposomes, micelles and nanoparticles a new frontier was opened for improving drug delivery. Nanoparticles with their special characteristics such as small particle size, large surface area and the capability of changing their surface properties have numerous advantages compared with other delivery systems. Targeted nanoparticle delivery to the lungs is an emerging area of interest. This article reviews research performed over the last decades on the application of nanoparticles administered via different routes of administration for treatment or diagnostic purposes. Nanotoxicological aspects of pulmonary delivery are also discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to i.v. administration, i.t. administration via suspension nebulization or dry powder inhalation can directly deliver mRNA to the airways of the lungs.[184]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [184]
In the citing paper
“Moreover, using i.t. administration, mRNA can be delivered to a variety of cell types, such as alveolar cells, pulmonary endothelium, and immune cells.[126, 184]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [184]
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
Köhler, G., & Milstein, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,200
Oberdörster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., Carter, J., Karn, B., Kreyling, W., Lai, D., et al. (2005) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-2-8 · Cited by 2,134
Hillery, A. M., Lloyd, A. W., & Swarbrick, J. (2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Xia, T., Kovochich, M., Brant, J. A., Hotze, M., Sempf, J. M., Oberley, T. D., Sioutas, C., Yeh, J. I., Wiesner, M. R., & Nel, A. E. (2006) · Nano Letters · doi:10.1021/nl061025k · Cited by 1,931
Comparative Pulmonary Toxicity Assessment of Single-wall Carbon Nanotubes in Rats
Warheit, D. B. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg228 · Cited by 1,531
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J. S., Caponetti, G., Hrkach, J. S., Ben-Jebria, A., Eskew, M. L., Mintzes, J. D., Deaver, D. R., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,184
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Sayes, C. M., Reed, K. L., & Warheit, D. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm018 · Cited by 769
The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis
Gelperina, S. E., Kisich, K. O., Iseman, M. D., & Heifets, L. B. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-613pp · Cited by 744
Green, M. R., Manikhas, G. M., Орлов, С. В., Afanasyev, B. V., Makhson, A. M., Bhar, P., & Hawkins, M. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 671
Flagged first, then by citations
4 of the 99 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Clark, 2002, Formulation of proteins and peptides for inhalation, Drug Deliv. Syst. Sci., 2, 73
- Page, 1996, Entrapment of colistin into polyhexylcyanoacrylate nanoparticles: preparation, drug release and tissue distribution in mice, S.T.P. Pharm. Sci., 6, 298
- Leucuta, 2003, Preparation and pharmaceutical/pharmacokinetic characterization of liposomes and nanoparticles loaded with epirubicin, S.T.P. Pharm. Sci., 13, 291
- Shvedova, 2003, Exposure to carbon nanotube material: evidence of exposure-induced oxidant stress in human keratinocyte and bronchial epithelial cells, Free Radic. Res., 37, 97
Cited by
Sorted by citations
Items 201–300 of 439
Novel technologies: A weapon against tuberculosis
Hari, B. V., Chitra, K., Bhimavarapu, R., Karunakaran, P., Muthukrishnan, N., & Rani, B. S. (2010) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.71887 · Cited by 32
Restani, R. B., Silva, A. S., Pires, R. F., Cabral, R. P., Correia, I. J., Casimiro, T., Bonifácio, V. D. B., & Aguiar‐Ricardo, A. (2016) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201600123 · Cited by 31
Lung cancer: active therapeutic targeting and inhalational nanoproduct design
Alhajj, N., Chee, C. F., Wong, T. W., Rahman, N. A., Kasim, N. H. A., & Colombo, P. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1547280 · Cited by 31
de Almeida, B. G., Lemes, T. H., Byzynski, G., Paziani, M. H., Kress, M. R. V. Z., de Almeida, M. T. G., & Volanti, D. P. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b00091 · Cited by 31
Targeted drug delivery via caveolae-associated protein PV1 improves lung fibrosis
Marchetti, G. M., Burwell, T. J., Peterson, N. C., Cann, J. A., Hanna, R. N., Li, Q., Ongstad, E. L., Boyd, J. T., Kennedy, M. A., Zhao, W., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0337-2 · Cited by 31
Loret, T., de Luna, L. A. V., Fordham, A., Arshad, A., Barr, K., Lozano, N., Kostarelos, K., & Bussy, C. (2022) · Advanced Science · doi:10.1002/advs.202104559 · Cited by 29
Loret, T., de Luna, L. A. V., Lucherelli, M. A., Fordham, A., Lozano, N., Bianco, A., Kostarelos, K., & Bussy, C. (2023) · Small · doi:10.1002/smll.202301201 · Cited by 33
Characteristics of turbulent particle transport in human airways under steady and cyclic flows
Jedelský, J., Lízal, F., & Jícha, M. (2012) · International Journal of Heat and Fluid Flow · doi:10.1016/j.ijheatfluidflow.2012.01.003 · Cited by 30
Chemical glycosylation of cytochrome c improves physical and chemical protein stability
Delgado, Y., Morales‐Cruz, M., Hernández-Román, J., Martínez, Y., & Griebenow, K. H. (2014) · BMC Biochemistry · doi:10.1186/1471-2091-15-16 · Cited by 30
Navarrette, C. R., Sisson, J. H., Nance, E. A., Allen‐Gipson, D., Hanes, J. S., & Wyatt, T. A. (2012) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2011.0890 · Cited by 30
Influence of excipients on spray-dried powders for inhalation
Xu, E., Guo, J. B., Xu, Y., Li, H., & Seville, P. C. (2014) · Powder Technology · doi:10.1016/j.powtec.2014.02.033 · Cited by 30
Initial Observations of Cell-Mediated Drug Delivery to the Deep Lung
Kumar, A. B., Glaum, M. C., El‐Badri, N., Mohapatra, S. S., Haller, E. M., Park, S., Patrick, L., Nattkemper, L. A., Vo, D., & Cameron, D. F. (2010) · Cell Transplantation · doi:10.3727/096368910x536491 · Cited by 30
Advances in Spray Drying Technology for Nanoparticle Formation
Wong, T. W., & John, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-15338-4_18 · Cited by 29
D’Addio, S. M., Reddy, V. M., Liu, Y., Sinko, P. J., Einck, L., & Prud’homme, R. K. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5008663 · Cited by 29
In Vitro and In Vivo Lung Deposition of Coated Magnetic Aerosol Particles
Xie, Y., Longest, P. W., Xu, Y. H., Wang, J., & Wiedmann, T. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22168 · Cited by 29
Huang, W.-T., Larsson, M., Wang, Y.-J., Chiou, S., Lin, H.-Y., & Liu, D. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500747w · Cited by 29
Nanoparticles in the treatment of chronic lung diseases
Alexescu, T., Țărmure, S., Negrean, V., Cosnarovici, M. M., Ruta, V. M., Popovici, I., Para, I., Perné, M.-G., Orasan, O. H., & Todea, D. A. (2019) · Journal of Mind and Medical Sciences · doi:10.22543/7674.62.p224231 · Cited by 28
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus
Majumder, J., & Minko, T. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000203 · Cited by 30
Yu, Y., Li, S., Yao, Y., Shen, X., Li, L., & Huang, Y. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.06.016 · Cited by 29
Liposome-anchored mesenchymal stem cells for radiation pneumonia/fibrosis treatment
Zhou, H., Zhang, Y., Pei, P., Shen, W., Yi, X., & Yang, K. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122202 · Cited by 28
Nishimura, S., Takami, T., & Murakami, Y. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.08.004 · Cited by 28
Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers
Umerska, A. M., Mouzouvi, C. R., Bigot, A. K., & Saulnier, P. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.008 · Cited by 28
Long-acting inhaled medicines: Present and future
Zhang, C., D’Angelo, D., Buttini, F., & Yang, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115146 · Cited by 28
Song, X., Wei, J., Cai, X., Liu, Y., Wu, F., Tong, S., Li, S., Yao, Q., Xie, J., & Yang, H. (2024) · ACS Nano · doi:10.1021/acsnano.4c11509 · Cited by 27
Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers
Xu, X., Zhao, C., Yang, H., Jian, Y., Zhang, Z., & Huang, Y. (2011) · Drug Delivery · doi:10.3109/10717544.2011.589087 · Cited by 27
Therapeutic nanosystems for oncology nanomedicine
Gonçalves, A. S., Macedo, A. S., & Souto, E. B. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0912-1 · Cited by 28
Yang, H., Hua, M., Liu, H.-L., Tsai, R., Pang, S., Hsu, P.-H., Tang, H.-J., Yen, T., & Chuang, C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.020 · Cited by 26
Distribution of Effervescent Inhalable Nanoparticles After Pulmonary Delivery: an In Vivo Study
Alhallak, K., Sarfraz, M., Azarmi, S., Roa, W., Finlay, W. H., Rouleau, C., & Löbenberg, R. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.42 · Cited by 26
Self-citationYordanov, G. G., Evangelatov, A., & Skrobanska, R. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.02.002 · Cited by 27
Combating tuberculosis infection: A forbidding challenge
Rawal, T., & Butani, S. (2016) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.180243 · Cited by 25
Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications
Chattopadhyay, S. (2013) · Journal of Liposome Research · doi:10.3109/08982104.2013.802332 · Cited by 25
Antioxidants & bronchopulmonary dysplasia: Beating the system or beating a dead horse?
Ofman, G., & Tipple, T. E. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.038 · Cited by 25
Sedaghat, M. H., Behnia, M. M., & Abouali, O. (2023) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2022.0049 · Cited by 25
Emerging therapies for smoke inhalation injury: a review
Mercel, A. I., Tsihlis, N. D., Maile, R., & Kibbe, M. R. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02300-4 · Cited by 24
Nanoparticles combined with growth factors: recent progress and applications
Chu, C., Deng, J., Liu, L., Cao, Y., Wei, X., Li, J., & Man, Y. (2016) · RSC Advances · doi:10.1039/c6ra13636b · Cited by 24
Valarini, O., Cardoso, F. A. R., Giufrida, W. M., de Souza, M. F., & Cardozo‐Filho, L. (2019) · Journal of CO2 Utilization · doi:10.1016/j.jcou.2019.08.025 · Cited by 24
Umerska, A. M., Mugheirbi, N. A., Kasprzak, A., Saulnier, P., & Tajber, L. (2020) · Powder Technology · doi:10.1016/j.powtec.2020.02.028 · Cited by 24
Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions
Beck‐Broichsitter, M., Knuedeler, M.-C., Oesterheld, N., Seeger, W., & Schmehl, T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.040 · Cited by 24
Silicon(IV) phthalocyanine-loaded-nanoparticles for application in photodynamic process
Simioni, A. R., Primo, F. L., & Tedesco, A. C. (2011) · Journal of Laser Applications · doi:10.2351/1.3669442 · Cited by 24
Arborescent Amphiphilic Copolymers as Templates for the Preparation of Gold Nanoparticles
Dockendorff, J., Gauthier, M., Mourran, A., & Möller, M. (2008) · Macromolecules · doi:10.1021/ma801320r · Cited by 24
Inhaled Atorvastatin Nanoparticles for Lung Cancer
Tulbah, A. S. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220426091500 · Cited by 22
Potencial risks of nanoparticles
Forbe, T., García, M. A., & Gonzalez, E. (2011) · Food Science and Technology · doi:10.1590/s0101-20612011000400002 · Cited by 22
Power, S., Slattery, M. M., & Lee, M. J. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-010-9967-y · Cited by 21
Takami, T., & Murakami, Y. (2014) · Langmuir · doi:10.1021/la500324j · Cited by 21
Inhaled Simvastatin Nanoparticles for Inflammatory Lung Disease
Tulbah, A. S., Pisano, E., Scalia, S., Young, P. M., Traini, D., & Ong, H. X. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0188 · Cited by 21
Nanomedicine in Cancer Clinics: Are We There Yet?
Nayak, P. P., Nijil, S., Vadakkepushpakath, A. N., Badekila, A. K., & Kini, S. (2021) · Current Pathobiology Reports · doi:10.1007/s40139-021-00220-6 · Cited by 21
Biofunctionalization of PEGylated Microcapsules for Exclusive Binding to Protein Substrates
Deo, D. I., Gautrot, J. E., Sukhorukov, G. B., & Wang, W. (2014) · Biomacromolecules · doi:10.1021/bm500412d · Cited by 20
Infectious Diseases: Need for Targeted Drug Delivery
Devarajan, P. V., Dawre, S., & Dutta, R. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_3 · Cited by 21
Safari, R., Yaghoubi, M., Marcinkowska‐Lesiak, M., Paya, H., Sun, X., Rastgoo, A., Rafiee, M., & Alirezalu, K. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3686 · Cited by 19
Fouad, S. A., Malaak, F. A., Teaima, M. H. M., Omar, S., Kutkat, O., Elhabal, S. F., & El-Nabarawi, M. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106196 · Cited by 19
Daear, W., Lai, P. K., Anikovskiy, M., & Prenner, E. J. (2015) · The Journal of Physical Chemistry B · doi:10.1021/jp5122239 · Cited by 19
Parasaram, V., Nosoudi, N., LeClair, R. J., Binks, A. P., & Vyavahare, N. R. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.06.004 · Cited by 19
Transfection of Pulmonary Cells by Stable pDNA -Polycationic Hybrid Nanostructured Particles
Gaspar, D. P., Vital, J., Leiva, M. C., Gonçalves, L., Taboada, P., Remuñán‐López, C., Vítor, J. M. B., & Almeida, A. J. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0270 · Cited by 19
Faraj, A. A., Shaik, A. S., Afzal, S., Al‐Muhsen, S., & Halwani, R. (2015) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1678 · Cited by 20
A quantitative review of nanotechnology‐based therapeutics for kidney diseases
Cheng, H., Ta, Y. N., Hsia, T., & Chen, Y. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1953 · Cited by 18
O'Sullivan, J., Muñoz-Muñoz, J., Turnbull, G., Sim, N., Penny, S., & Moschos, S. A. (2022) · RSC Advances · doi:10.1039/d2ra01999j · Cited by 20
Wonders of Nanotechnology in the Treatment for Chronic Lung Diseases
Upadhyay, S., & Ganguly, K. (2015) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000337 · Cited by 18
Comparing the Dissolution Profiles of Seven Metformin Formulations in Simulated Intestinal Fluid
Stuart, A. V., Clement, Y. N., Sealy, P., Löbenberg, R., Montane-Jaime, L., Maharaj, R. G., & Maxwell, A. (2015) · Dissolution Technologies · doi:10.14227/dt220115p17 · Cited by 18
Self-citationNanoparticles for Pulmonary Delivery
Watts, A. B., & Williams, R. O. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9745-6_15 · Cited by 18
Tadalafil-loaded PLGA microspheres for pulmonary administration: preparation and evaluation
Yang, Z., Wang, L., Tian, L., Zhang, X., & Huang, G. (2019) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902019000217536 · Cited by 17
Babiuch, K., Pretzel, D., Kirchberger-Tolstik, T., Vollrath, A., Stanca, S. E., Foertsch, F., Becer, C. R., Gottschaldt, M., Biskup, C. U., & Schubert, U. S. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200024 · Cited by 17
Pulmonary Delivery of Butyrylcholinesterase as a Model Protein to the Lung
Rahhal, T. B., Fromen, C. A., Wilson, E. M., Kai, M. P., Shen, T. W., Luft, J. C., & DeSimone, J. M. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00066 · Cited by 17
Al‐Qadi, S., Taboada, P., & Remuñán‐López, C. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.049 · Cited by 17
Nanotechnology applications in thoracic surgery
Hofferberth, S. C., Grinstaff, M. W., & Colson, Y. L. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw002 · Cited by 16
Nanomedicine and therapy of lung diseases
Garcia, F. D. M. (2014) · Einstein (São Paulo) · doi:10.1590/s1679-45082014md3113 · Cited by 16
Khung, Y. L., Lee, W., Chui, K. L., Liu, Y., Lim, M. P. A., Huang, C. L., & Loo, S. C. J. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201100007 · Cited by 16
Nanocarriers for inhaled delivery of RNA therapeutics
Huayamares, S. G., Zenhausern, R., & Loughrey, D. (2024) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2024.100200 · Cited by 17
Development of Nanoscale Oil Bodies for Targeted Treatment of Lung Cancer
Chiang, C., Lin, L., Wu, C.-P., Chen, C., & Chao, Y. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02972 · Cited by 15
Microcalorimetric Method to Assess Phagocytosis: Macrophage-Nanoparticle Interactions
Alhallak, K., Sarfraz, M., Azarmi, S., Kohan, H. G., Roa, W., & Löbenberg, R. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9240-y · Cited by 15
Self-citationSimvastatin Nanoparticles Reduce Inflammation in LPS-Stimulated Alveolar Macrophages
Tulbah, A. S., Pisano, E., Landh, E., Scalia, S., Young, P. M., Traini, D., & Ong, H. X. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.029 · Cited by 16
Peptide Nanomedicines for Treatment of Acute Lung Injury
Sadikot, R. T. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00016-1 · Cited by 15
Anti‐Inflammatory Nanotherapies Based on Bioactive Cyclodextrin Materials
Li, L., Chen, B., Li, G., Chen, S., & Zhang, J. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300106 · Cited by 14
Raţă, D. M., Cadinoiu, A. N., Atanase, L. I., Popa, M., Mihai, C. T., & Vochița, G. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131027 · Cited by 14
Borowik, T., Przybyło, M., Pala, K., Otlewski, J., & Langner, M. (2011) · Spectrochimica Acta Part B Atomic Spectroscopy · doi:10.1016/j.sab.2011.09.008 · Cited by 14
Rigo, L. A., Carvalho‐Wodarz, C. D. S., Pohlmann, A. R., Guterres, S. S., Schneider‐Daum, N., Lehr, C.-M., & Beck, R. C. R. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.05.006 · Cited by 14
Wang, S., Ma, S., Li, R., Qi, X., Han, K., Guo, L., & Li, X. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167539 · Cited by 14
Modeling nanoparticle delivery of TB drugs to granulomas
Grobler, A., Sierra, Z. P., & Viljoen, H. J. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.10.004 · Cited by 14
Noraizaan, A. N., & Wong, T. W. (2017) · Powder Technology · doi:10.1016/j.powtec.2017.01.035 · Cited by 14
Current advances in the utilization of nanotechnology for the diagnosis and treatment of diabetes
Devadasu, V. R., Alshammari, T. M., & Aljofan, M. (2017) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-017-0558-1 · Cited by 16
Book Review: Review of a viral peptide nanosystem for intracellular delivery
Falanga, A., Tarallo, R., Galdiero, E., Cantisani, M., Galdiero, M., & Galdiero, S. (2013) · Journal of Nanophotonics · doi:10.1117/1.jnp.7.071599 · Cited by 14
The metabolic fate of iron-based magnetic nanomaterials and their impact on macrophage function
Huang, Y., Cai, X., Yan, L., Zhang, M., Sheng, J., & Gu, N. (2025) · Magnetic Medicine · doi:10.1016/j.magmed.2025.100002 · Cited by 14
Chaudhary, K. R., Singh, K., & Singh, C. (2023) · Current Drug Delivery · doi:10.2174/0115672018265571231011093546 · Cited by 14
Exploring the role of electrostatic deposition on inhaled aerosols in alveolated microchannels
Bessler, R., Bhardwaj, S., Malka, D., Fishler, R., & Sznitman, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-49946-w · Cited by 13
Enhanced oral and pulmonary delivery of biomacromolecules via amplified transporter targeting
Xiao, X., Zhang, L., Ni, M., Liu, X., Xing, L., Wu, L., Zhou, Z., Li, L., Wen, J., & Huang, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.04.026 · Cited by 13
Li, Z., Lu, S., Liu, W., Chen, Z., Huang, Y., Li, X., Gong, J., & Chen, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c00777 · Cited by 13
PEGylated Multimeric RNA Nanoparticles for siRNA Delivery in Traumatic Brain Injury
Han, S. W., Yoo, W., Carton, O., Joo, J., & Kwon, E. J. (2024) · Small · doi:10.1002/smll.202405806 · Cited by 13
Han, Y., Dong, J., Zhang, L., Yue, T., Zhao, W., Gao, C., Sun, J., & Zhang, R. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123169 · Cited by 13
Bridging micro/nano-platform and airway allergy intervention
Sun, M., Teng, Z., Fan, P., Chen, X., & Liu, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.040 · Cited by 13
Novel microencapsulated Pluronic–chitosan nanomicelles for lung delivery
Lin, H., Li, Y., & Lin, Y. (2016) · Colloid & Polymer Science · doi:10.1007/s00396-016-3879-6 · Cited by 13
Movia, D., Cristo, L. D., Alnemari, R., McCarthy, J. E., Moustaoui, H., de la Chapelle, M. L., Spadavecchia, J., Volkov, Y., & Prina‐Mello, A. (2017) · Journal of Interdisciplinary Nanomedicine · doi:10.1002/jin2.25 · Cited by 13
Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications
AbouSamra, M. M. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2377085 · Cited by 15
Nakagawa, K., Miyazawa, T., Harigae, T., Onuma, R., Kimura, F., Fujii, T., & Miyazawa, T. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s94336 · Cited by 12
Günday-Türeli, N., Türeli, A. E., & Schneider, M. (2014) · Drug Delivery Letters · doi:10.2174/2210303104666140222002101 · Cited by 12
Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases
Tian, Y., Chen, J., Zahtabi, F., Keijzer, R., & Xing, M. M. Q. (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22657 · Cited by 12
Morais, W. D. A., de Souza, J. G., García‐Villén, F., Loureiro, J. L., Raffin, F. N., Fernandes, M. A. C., Souto, E. B., Severino, P. B., & Barbosa, R. D. M. (2024) · World Journal of Pediatrics · doi:10.1007/s12519-024-00834-x · Cited by 14
Ahmad, T., Kadam, P. P., Bhiyani, G., Ali, H., Akbar, M., Siddique, M. U. M., & Shahid, M. (2024) · Diseases · doi:10.3390/diseases12100230 · Cited by 11
Heidari, S., Akhlaghi, M., Sadeghi, M., Kheirabadi, A. M., Beiki, D., Emami-Ardekani, A., Rouhollah, A., Saeidzadeh, P., & Soleyman, R. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103477 · Cited by 11
Tulbah, A. S. (2023) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2023.02.014 · Cited by 11
Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm
Javed, & Yadav, S. (2023) · Medical Oncology · doi:10.1007/s12032-023-02104-8 · Cited by 11
Nanopharmaceuticals: A New Perspective of Drug Delivery System
Saad, M. Z. H., Jahan, R., & Bagul, U. S. (2012) · Asian journal of biomedical and pharmaceutical sciences · doi:10.15272/ajbps.v2i14.123 · Cited by 11
Metadata
- Authors
- Azarmi, S., Roa, W. H., & Löbenberg, R.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Löbenberg, Raimar
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 60
- Issue
- 8
- Pages
- 863-875
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1972609612
- Cited by
- 440
- References
- 99
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 22 · 2023: 25 · 2022: 27 · 2021: 25 · 2020: 24 · 2019: 23 · 2018: 18 · 2017: 21 · 2016: 27 · 2015: 28 · 2014: 35 · 2013: 25 · 2012: 33
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- targeted drug delivery, nanoparticles, lung disease, pulmonary drug delivery, liposomes, micelles, colloidal drug delivery systems, route of administration, nanotoxicology
- MeSH terms
- Animals, Antibodies, Monoclonal, Humans, Lung, Lung Diseases, Magnetics, Drug Delivery Systems, Gene Transfer Techniques, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review